Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET

Author： Cools R.

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.125, Iss.3, 2002-03, pp. : 584-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aberrant sexual behaviours in Parkinson’s disease during dopaminergic treatment

By Cannas Antonino Solla Paolo Floris Gian Serra Giulia Tacconi Paolo Marrosu Maria

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 110-112

Springer Publishing Company

Access to resources Recommend Favorite

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

By Bohnen Nicolaas Gedela Satyanarayana Kuwabara Hiroto Constantine Gregory Mathis Chester Studenski Stephanie Moore Robert

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

Gait variability in Parkinson’s disease: influence of walking speed and dopaminergic treatment

By Bryant Mon S Rintala Diana H Hou Jyhgong G Charness Ann L Fernandez Angel L Collins Robert L Baker Jeff Lai Eugene C Protas Elizabeth J

Neurological Research, Vol. 33, Iss. 9, 2011-11 ,pp. : 959-964

Maney Publishing

Access to resources Recommend Favorite

Role of DJ-1 in parkinson’s disease

By Lev Nirit Roncevich Dusan Ickowicz Debby Melamed Eldad Offen Daniel

Journal of Molecular Neuroscience, Vol. 31, Iss. 3, 2007-05 ,pp. : 307-307

Humana Press, Inc

Access to resources Recommend Favorite

Role of imaging in drug development for Parkinson’s disease

By Brooks David J

Future Neurology, Vol. 1, Iss. 3, 2006-05 ,pp. : 335-342

Future Medicine

Access to resources Recommend Favorite